Biotechnology - Ocoee, Florida, United States
Our genetically-engineered, universal iPSCs-derived immune effector cell products (NK, T, Dendritic cells, and macrophage) are designed to specifically target hematologic and solid tumor cancers. Our commitment to developing off-the-shelf cell therapies will expand patient access and provides an unparalleled opportunity to advance the course of cancer care.
Outlook
Amazon CloudFront
Amazon Elastic Load Balancer
Microsoft Office 365
Amazon AWS
Adobe Marketing Cloud